Cardiopulmonary Bypass Equipment Devices Market Size was valued at USD 0.152 Billion in 2022. The Cardiopulmonary Bypass Equipment Devices market industry is projected to grow from USD 0.155 Billion in 2023 to USD 0.184 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 2.20% during the forecast period (2023 - 2032). Increased prevalence of cardiovascular diseases and rising demand for cardiac surgeries are the key market drivers fueling the market growth.
Market CAGR for cardiopulmonary bypass equipment devices is being driven by the escalating prevalence of cardiovascular diseases (CVDs) globally. Cardiovascular diseases, including coronary artery disease, valvular heart disease, and congenital heart defects, continue to be a leading cause of morbidity and mortality. As the incidence of these conditions rises due to factors such as aging populations, sedentary lifestyles, and dietary changes, the demand for cardiac interventions and surgeries also increases.
Cardiopulmonary bypass (CPB) plays a crucial role in cardiac surgeries by temporarily taking over the function of the heart and lungs, allowing surgeons to perform intricate procedures. With the growing burden of cardiovascular diseases, there is a parallel increase in the number of cardiac surgeries, creating a sustained demand for Cardiopulmonary Bypass Equipment Devices. Hospitals and healthcare facilities, recognizing the need to address the rising cases of heart-related conditions, are investing in advanced CPB technologies to enhance patient outcomes and improve the overall efficacy of cardiac procedures.
Advancements in perfusion technologies represent a significant driver propelling the Cardiopulmonary Bypass Equipment Devices market forward. Perfusion refers to the process of supplying oxygen and nutrients to the body's tissues and organs while removing waste products. In the context of cardiac surgeries, perfusion technology is employed to maintain adequate blood circulation and oxygenation during the period when the heart is temporarily stopped for the surgical procedure.
Additionally, rising awareness among healthcare professionals and patients about the benefits of cardiopulmonary bypass in complex cardiac surgeries is another key driver of market growth. As medical knowledge and education continue to advance. There is a greater demand for the role of CPB in enabling intricate and life-saving cardiac procedures. The temporary suspension of heart and lung function provided by CPB allows surgeons the necessary time and conditions to perform surgeries with precision.
According to the World Health Organization (WHO), cardiovascular diseases are the leading cause of death globally, accounting for an estimated 17.9 million deaths annually. The American Heart Association reports that nearly half of all adults in the United States have some form of cardiovascular disease. As a result, it is anticipated that throughout the projection period, demand for Cardiopulmonary Bypass Equipment Devices will increase due to the rising preference for Cardiopulmonary Bypass Equipment Devices. Thus, driving the Cardiopulmonary Bypass Equipment Devices market revenue.
The Cardiopulmonary Bypass Equipment Devices Market segmentation, based on product type includes Single Roller Pump and Double Roller Pump. The double roller pump segment dominated the market, accounting for more than half of market revenue. This is attributed to its advantages over single roller pumps in terms of stability, precision, and reduced pulsatility in blood flow during cardiopulmonary bypass procedures.
The Cardiopulmonary Bypass Equipment Devices Market segmentation, based on End User includes Hospitals and Ambulatory Surgical Centres. The hospitals segment dominated the market, accounting for above half of market revenue. Hospitals serve as the primary hubs for complex cardiac surgeries and interventions that require cardiopulmonary bypass.
Figure 1: Cardiopulmonary Bypass Equipment Devices Market, by End User, 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
By region, the study provides market insights into North America, Europe, Asia-Pacific, and Rest of the World. The North American Cardiopulmonary Bypass Equipment Devices market area will dominate this market. North America region has advanced healthcare infrastructure and a high level of awareness regarding cardiovascular diseases. The prevalence of cardiac conditions, coupled with a well-established healthcare system, leads to a significant demand for cardiac surgeries and related technologies.
Further, the major countries studied in the market report are The US, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 2: CARDIOPULMONARY BYPASS EQUIPMENT DEVICES MARKET SHARE BY REGION 2022 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe Cardiopulmonary Bypass Equipment Devices market accounts for the second-largest market share owing to its well-developed healthcare infrastructure, a large patient population with cardiovascular diseases, and a strong emphasis on technological advancements in medical care. Further, the German Cardiopulmonary Bypass Equipment Devices market held the largest market share, and the UK Cardiopulmonary Bypass Equipment Devices market was the fastest-growing market in the European region
The Asia-Pacific Cardiopulmonary Bypass Equipment Devices Market is expected to grow at the fastest CAGR from 2023 to 2032. The region's large and aging population is experiencing a rise in the prevalence of cardiovascular diseases, creating a growing demand for cardiac interventions. Improved economic conditions in several Asia-Pacific countries have increased healthcare spending, allowing for greater access to advanced medical treatments, including cardiac surgeries. Moreover, China’s Cardiopulmonary Bypass Equipment Devices market held the largest market share, and the Indian Cardiopulmonary Bypass Equipment Devices market was the fastest growing market in the Asia-Pacific region.
Leading market players are investing heavily in research and development to introduce innovative and technologically advanced Cardiopulmonary Bypass Equipment Devices. Market participants are also adopting a variety of strategic activities to expand their worlwide footprint, with important market developments including new product launches, contractual agreements, Customer Education and Training, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, Cardiopulmonary Bypass Equipment Devices industry must offer innovative solution.
Offering customization options and tailored solutions to meet the specific needs of different healthcare facilities is one of the key business tactics used by manufacturers in the global Cardiopulmonary Bypass Equipment Devices industry to increase the market share. In recent years, the Cardiopulmonary Bypass Equipment Devices industry has offered some of the most significant advantages to Consumers. Major players in the Cardiopulmonary Bypass Equipment Devices market, including Medtronic Plc, LivaNova PLC, Braile Biomedica, Tianjin Medical, MAQUET Holding B.V. & Co. KG., Terumo Corporation, and others, are attempting to increase market demand by offering Post-Sale Support and Service to contributes to customer satisfaction.
Medtronic is a big healthcare technology company that's making a difference in global health. They have a huge team of over 95,000 people in more than 150 countries. Medtronic is focused on making healthcare technology more available, supporting inclusion, diversity, and fairness, and caring about the environment. Their mission, based on biomedical engineering, is all about creating, making, and sharing tools that help with pain, bring back health, and make life longer. Medtronic is really committed to helping people, and they work hard to find new solutions that make a positive impact on lives and improve healthcare worldwide. In November 2023, Medtronic plc introduced its Penditure Left Atrial Appendage (LAA) Exclusion System in the United States. This system includes an inventive, implantable clip that is pre-loaded on a single-use delivery tool. It is designed for managing the left atrial appendage (LAAM) during concurrent cardiac surgery procedures.
LivaNova, PLC, is a company that makes special medical devices for heart surgery and neuromodulation. It started in 2015 when two companies, Cyberonics, Inc. from Texas and Sorin S.p.a. from Italy, joined together in a big merger worth $2.7 billion. LivaNova quickly became a big player in the global healthcare industry. You can find its stock trading on the NASDAQ stock exchange under the symbol "LIVN." LivaNova is all about using the latest medical technologies to improve patient care in heart surgery and neuromodulation. This merger made LivaNova a strong force in the market, combining the skills and knowledge of two experienced companies to create new and better ways to help people. In April 2022, LivaNova obtained FDA 510(k) clearance for its B-Capta system, which was integrated into the S5 heart-lung machine.
Key Companies in the Cardiopulmonary Bypass Equipment Devices Market Include
Cardiopulmonary Bypass Equipment Devices Industry Developments
April 2022: LivaNova started the targeted commercial launch of Essenz™, a Patient Monitor designed for cardiopulmonary bypass procedures. The innovative monitoring system adopts a patient-tailored approach to enhance clinical efficiency and the quality of patient care during cardiopulmonary bypass (CPB) procedures.
February 2022: Getinge obtained 100% of the equity interest in Talis Clinical LLC, a leading innovator of High Acuity cloud-based software solutions based in the US. Talis Clinical's offerings were designed to support and document care across various healthcare processes, including general and cardiac perioperative care, labor and delivery episodes, and critical care support, including ECMO Therapy.
| Report Attribute/Metric | Details |
| Market Size 2022 | USD 0.152 Billion |
| Market Size 2023 | USD 0.155 Billion |
| Market Size 2032 | USD 0.184 Billion |
| Compound Annual Growth Rate (CAGR) | 2.20% (2023-2032) |
| Base Year | 2022 |
| Market Forecast Period | 2023-2032 |
| Historical Data | 2018- 2022 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Product Type, End User, and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and the Rest of the World |
| Countries Covered | The US, Canada, German, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled | Medtronic Plc, LivaNova PLC, Braile Biomedica, Tianjin Medical, MAQUET Holding B.V. & Co. KG., and Terumo Corporation |
| Key Market Opportunities | · Technological Advancements in Perfusion Technologies is fueling the market growth |
| Key Market Dynamics | · Growing Prevalence of Cardiovascular Diseases is driving the market growth |
Frequently Asked Questions (FAQ) :
The Cardiopulmonary Bypass Equipment Devices Market size was valued at USD 0.152 Billion in 2022.
The global market is projected to grow at a CAGR of 2.20% during the forecast period, 2023-2032.
North America had the largest share in the global market
The key players in the market are Medtronic Plc, LivaNova PLC, Braile Biomedica, Tianjin Medical, MAQUET Holding B.V. & Co. KG., and Terumo Corporation
The Double Roller Pump category dominated the market in 2022.
The Hospitals had the largest share in the global market.
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
